Why Wegovy Causes Burping — and What the Evidence Says

What the STEP 1 trial data tell us about burping on semaglutide

The STEP 1 trial (a 68-week study of semaglutide 2.4mg published in the New England Journal of Medicine) documented eructation as part of a broader pattern of upper-gastrointestinal adverse events that affected participants on semaglutide at higher rates than those taking placebo. This was not a marginal finding. Nausea, vomiting, diarrhoea, constipation and burping together formed the recognisable GI fingerprint of GLP-1 receptor agonists, and burping sat within that cluster. The intensity was rated predominantly mild to moderate, and rates of discontinuation specifically for burping were low. Crucially, the events were most frequent during the dose-escalation phase and declined once participants settled at their maintenance dose. This trajectory matters: for most people, burping is a temporary feature of early treatment, not a permanent fixture. The NHS medicines page for semaglutide lists burping explicitly among the common side effects you may notice, particularly in the first few weeks.

Why semaglutide slows the stomach — and why that causes burping

GLP-1 receptor agonists like semaglutide work partly by delaying gastric emptying: food moves out of the stomach into the small intestine more slowly than it normally would. That slowdown is part of what creates the fullness signal that helps people eat less. It also, however, means that gas produced during digestion (or air swallowed while eating) has more time to accumulate in the upper digestive tract before it can pass downward. The result is that gas takes the path of least resistance upward instead. If you have been wondering whether Wegovy makes you burp a lot and what drives that pattern, the slowed-emptying effect is central to the answer. The slowed-emptying effect tends to be most pronounced after eating a large meal or eating quickly, which is why meal composition and pace genuinely affect symptom severity on this medicine. It is not simply a matter of sensitivity, it is a predictable physiological response to how semaglutide acts on the gut.

Practical steps that can reduce burping frequency

There is no medication specifically indicated for burping on Wegovy, and that is not what most people need. Adjustments to eating habits tend to make a meaningful difference. Eating smaller portions more slowly (putting the fork down between bites) gives the stomach a more manageable volume to process. Carbonated drinks are worth avoiding, at least while symptoms are noticeable; they add gas directly at a time when the stomach is already under pressure. Lying down immediately after eating can worsen reflux-adjacent symptoms including burping, so a short upright period after meals helps. Some people find that certain foods (particularly high-fat meals) make things considerably worse, because fat delays gastric emptying independently of the medicine, compounding the effect. If you want to understand whether Wegovy makes you burp and why it happens, that question is explored in more depth separately. People taking Wegovy sometimes also notice that their burps carry an unpleasant eggy smell, and why sulfur burps happen on Wegovy and what you can do about them is covered in its own dedicated page. The broader side effect profile of Wegovy covers the full GI picture if you want to see where burping fits alongside the other commonly reported effects. One question our prescribers hear regularly is whether the burps people get on Wegovy mean the treatment is not working, or should be stopped, the answer in most cases is neither. It is a side effect to manage, not a signal that the medicine is failing.

When burping warrants a conversation with a prescriber

Most burping on Wegovy settles within a few weeks. If it has not eased after a month at a stable dose, or if it is accompanied by severe stomach pain that radiates toward the back, persistent vomiting, or signs of significant dehydration, those are reasons to seek medical advice promptly. The MHRA has highlighted acute pancreatitis as a serious but uncommon risk with GLP-1 medicines, severe, persistent abdominal pain is the key symptom to watch for and act on quickly. Burping alone, without those warning features, is not a red flag. You can report any unexpected or troubling side effects through the MHRA's Yellow Card scheme, which helps regulators track the real-world safety profile of medicines like Wegovy. If you are on Wegovy privately and feel unsure whether what you are experiencing is within the normal range, our clinical team is available seven days a week, the contact page has details. For anyone still weighing up whether semaglutide is the right treatment for their situation, exploring the full Wegovy overview is a reasonable starting point, and checking your eligibility with our prescribers costs nothing.